@PersonaDx_ Profile picture

PersonaDx

@PersonaDx_

Personalizing Cancer Treatment and Diagnosis using state-of-the-art AI-based tissue and blood tests

Joined July 2023
PersonaDx Reposted

Patients with metastatic or advanced cancer treated at practices with higher National Quality Forum 0210 rates did not have improved survival. ja.ma/3Wv7VsP

Tweet Image 1

PersonaDx Reposted

Sharing the Burden: The Case for Definitive Local Therapy in Place of Immune Checkpoint Blockade for Patients With a Low-Volume Burden of Metastatic Disease: ascopubs.org/doi/10.1200/JC… @ConnorLynchMD @MuzamilArshad18 @RohanKatipally @rweichselbaum @UCCancerCenter


Electronic Survey Helps Integrate Exercise as Standard of Care at UPMC Hillman Cancer Center inside.upmc.com/ajtvgm8f-t via @UPMCnews


PersonaDx Reposted

I’m thrilled to announce that @theNCI renewed our designation as a Comprehensive Cancer Center for the high-impact work we do for cancer patients and the community. ow.ly/HUOc50R5Jut #NothingWillStopUs #WeAreNCIDesignated #UChiCancer50 @KunleOdunsiMD


PersonaDx Reposted

Register today for a groundbreaking, in-person accredited continuing education conference that elevate your practice by providing cutting-edge knowledge and fostering interdisciplinary collaboration. @UCCancerCenter #TheUChicago2024AYAOncologySymposium ow.ly/K7IQ50QMXZO

Tweet Image 1

Reconciling the discrepancies in randomized data of combining immunoth... sciencedirect.com/science/articl…


PersonaDx Reposted

March is #ColorectalCancerAwarenessMonth. To learn more about #ColorectalCancer, visit our Cancer Stat Facts sheet: seer.cancer.gov/statfacts/html… and SEER*Explorer: seer.cancer.gov/explorer

Tweet Image 1

PersonaDx Reposted

1/ For #KidneyCancerAwareness month @TheLancetOncol has a 50-day full link to @TROGfightcancer FASTRACK II! authors.elsevier.com/a/1ifvZ5EIIgPd…. Thank you @CancerAustralia, @ANZUPtrials, @VarianMedSys A new #radiotherapy standard of care option for inoperable primary #kidneycancer #radonc


PersonaDx Reposted

I am pleased to share our editorial on tumor aneuploidy as a novel, complementary predictor of immunotherapy response in patients receiving immune checkpoint blockade: nature.com/articles/s4169… @lfspurr @Ludwig_Cancer @LUNGevity @UCCancerCenter @UChicagoMed @UChicagoRadonc


And a great start it is!

Proud to start out the new year with the publication of my and @SeanPitroda’s editorial out today in @Nature_NPJ: nature.com/articles/s4169…



PersonaDx Reposted

Also, we should be submitting a paper in about two weeks that shows high-dose radiation seems to promote the growth of micro metastasis outside of the field and some patients a small element of this is in Wangcancer sold this year It’s hard to say how often this happens but


PersonaDx Reposted

In the “Ask a scientist” feature in the Fall 2023 Ludwig Link, researchers share their views on how to build public support for research. (bit.ly/3uIWHoQ) #AskAScientist

Tweet Image 1

Congratulations Chuan!

Congratulations to Ludwig @UChicagoMed's Chuan He on this exciting new study linking a fatty acid found in meat and dairy products to improved immune responses to cancer and a potential dietary booster of cancer immunotherapy. Read more here: bit.ly/47Wi04U

Tweet Image 1


Rest in Peace Dr. Taniguchi.

The ASTRO #RadOnc community mourns the loss of Dr. Cullen Taniguchi. Condolences to his family and friends.



United States Trends
Loading...

Something went wrong.


Something went wrong.